Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development

GLIA

Volumn 50, Issue 2, 2005, Pages 132-144

  Agresti, C ^a   Meomartini, M E ^b   Amadio, S ^b   Ambrosini, E ^a   Serafini, B ^a   Franchini, L ^a   Volonte C ^b   Aloisi, F ^a   Visentin, S ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

ATP; Cell motility; Intracellular calcium; P2X7; P2Y1; Remyelination

Indexed keywords

2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; FURA 2; IONOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 2; OXIDIZED ADENOSINE TRIPHOSPHATE; PLATELET DERIVED GROWTH FACTOR; PURINE P2 RECEPTOR; PURINE P2X1 RECEPTOR; PURINE P2X2 RECEPTOR; PURINE P2X3 RECEPTOR; PURINE P2X4 RECEPTOR; PURINE P2X7 RECEPTOR; PURINE P2Y RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y2 RECEPTOR; PURINE P2Y4 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; GLIA CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; WESTERN BLOTTING; WHOLE CELL; ANIMAL; CALCIUM SIGNALING; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; CELL SURVIVAL; CEREBELLUM; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; ELECTROPHYSIOLOGY; GROWTH, DEVELOPMENT AND AGING; IMMUNOHISTOCHEMISTRY; METABOLISM; NEUTROPHIL CHEMOTAXIS; NEWBORN; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; STEM CELL; WISTAR RAT;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CEREBELLUM; CHEMOTAXIS, LEUKOCYTE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ELECTROPHYSIOLOGY; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; OLIGODENDROGLIA; ORGAN CULTURE TECHNIQUES; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2; STEM CELLS;

EID: 18244367900     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20160     Document Type: Article

References (58)

1. Agresti C, D'Urso D, Levi G. 1996. Reversible inhibitory effects of interferon-γ and tumour necrosis factor-α on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur J Neurosci 8:1106-1116.
2. Amadio S, D'Ambrosi N, Cavaliere F, Murra B, Sancesario G, Bernardi G, Burnstock G, Volonté C. 2002. P2 receptor modulation and cytotoxic function in cultured CNS neurons. Neuropharmacology 42:489-501.
3. Armstrong RC, Harvath L, Dubois-Dalcq ME. 1990. Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules. J Neurosci Res 27:400-407.
4. Ballerini P, Di Iorio P, Ciccarelli R, Nargi E, D'Alimonte I, Traversa U, Rathbone MP, Caciagli F. 2002. Glial cells express multiple ATP binding cassette proteins which are involved in ATP release. NeuroReport 13:1789-1792.
5. Bernstein M, Lyons SA, Möller T, Kettenmann H. 1996. Receptor-mediated calcium signalling in glial cells from mouse corpus callosum slices. J Neurosci Res 46:152-163.
6. 7-receptor subunit in neurons of the rat retina. Brain Res Mol Brain Res 62:106-109.
7. 7 and oxygen/glucose deprivation in organotypic hippocampal cultures. J Cereb Blood Flow Metab 24:392-398.
8. Coco S, Calegari F, Pravettoni E, Pozzi D, Taverna E, Rosa P, Matteoli M, Verderio C. 2003. Storage and release of ATP from astrocytes in culture. J Biol Chem 278:1354-1362.
9. D'Ambrosi N, Murra B, Cavaliere F, Amadio S, Bernardi G, Burnstock G, Volonté C. 2001. Interaction between ATP and nerve growth factor signalling in the survival and neuritic outgrowth from PC12 cells. Neurosci 108:527-534.
10. Decker I, Avellana-Adalid V, Nait-Oumesmar B, Durbec P, Baron-Van Evercooren A. 2000. Oligodendrocyte precursor migration and differentiation: combined effects of PSA residues, growth factors, and substrates. Moll Cell Neurosci 16:422-439.
11. 7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J Neurosci 21:7143-7152.
12. Ferrari D, Chiozzi P, Falzoni S, Hanau S, Di Virgilio F. 1997. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J Exp Med 185:579-582.
13. Fields RD, Stevens B. 2000. ATP: an extracellular signaling molecule between neurons and glia. Trends Neurosci 23:625-633.
14. Franklin RJM. 2002. Why does remyelination fail in multiple sclerosis? Nature Rev Neurosci 3:705-714.
15. Frost EE, Milner R, ffrench-Constant C. 2000. Migration assays for oligodendrocyte precursor cells. In: Steruli C, Grant M, editors. Extracellular matrix protocols. Humana Press: Totowa, NJ. p 265-278.
16. Fumagalli M, Brambilla R, D'Ambrosi N, Volonté C, Matteoli M, Verderio C, Abbracchio MP. 2003. Nucleotide-mediated calcium signalling in rat cortical astrocytes: role of P2X and P2Y receptors. Glia 43:218-230.
17. Greig AV, Linge C, Cambrey A, Burnstock G. 2003. Purinergic receptors are part of a signaling system for keratinocyte proliferation, differentiation, and apoptosis in human fetal epidermis. J Invest Dermatol 121:1145-1149.
18. Grinspan J. 2002. Cell and signaling in oligodendrocyte development. J Neuropathol Exp Neurol 61:297-306.
19. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. 1981. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391:85-100.
20. He M, McCarthy KD. 1994. Oligodendroglial signal transduction systems are developmentally regulated. J Neurochem 63:501-508.
21. Hervas C, Perez-Sen R, Miras-Portugal MT. 2003. Coexpression of functional P2X and P2Y nucleotide receptors in single cerebellar granule cells. J Neurosci Res 73:384-399.
22. Honda S, Sasaki Y, Ohsawa K, Imai Y, Nakamura Y, Inoue K, Kohsaka S. 2001. Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J Neurosci 21:1975-1982.
23. Idzko M, Dichmann S, Ferrari D, Di Virgilio F, la Sala A, Girolomoni G, Panther E, Norgauer J. 2002. Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2Y receptors. Blood 100:925-932.
24. James G, Butt AM. 2001. P2X and P2Y purinoreceptors mediate ATP-evoked calcium signalling in optic nerve glia in situ. Cell Calcium 30:251-259.
25. 2+ signalling in glial cell pathology in the central nervous system. Eur J Pharmacol 447:247-260.
26. Kastritsis CH, McCarthy KD. 1993. Oligodendroglial lineage cells express neuroligand receptors. Glia 8:106-113.
27. Khakh B, Burnstock G, Kennedy C, King BF, North RA, Séguéla P, Voigt M, Humphrey PPA. 2001. International Union of Pharmacology. XXIV Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53:107-118.
28. 2+ release from InsP3-sensitive internal stores in mammalian oligodendrocytes. J Physiol 483:41-57.
29. Lazarowski ER, Boucher RC, Harden TK. 2000. Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations. J Biol Chem 275:31061-31068.
30. Le Feuvre R, Brough D, Rothwell N. 2002. Extracellular ATP and P2X7 receptors in neurodegeneration. Eur J Pharmacol 47:261-269.
31. Levi G, Aloisi F, Wilkin GP. 1987. Differentiation of cerebellar bipotential glial precursors into oligodendrocytes in primary culture: developmental profile of surface antigens and mitotic activity. J Neurosci Res 18:407-417.
32. Levi G, Gallo V, Ciotti MT. 1986. Bipotential precursors of putative fibrous astrocytes and oligodendrocytes in rat cerebellar cultures express distinct surface features and "neuron-like" gamma-aminobutyric acid transport. Proc Natl Acad Sci USA 83:1504-1508.
33. Milner R, Anderson HJ, Rippon RF, McKay JS, Franklin RJ, Marchionni MA, Reynolds R, ffrench-Constant C. 1997. Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migration. Glia 19:85-90.
34. 1 purinergic receptor in the human brain: striking neuronal localisation. J Comp Neurol 421:374-384.
35. 1 purinergic receptor in neurons and glial cells of the central nervous system. Brain Res Mol Brain Res 78:50-58.
36. Neary JT, Rathbone MP, Cattabeni F, Abbracchio MP, Burnstock G, 1996. Trophic actions of extracellular nucleotides on glia and neuronal cells. Trends Neurosci 19:13-18.
37. Othman T, Yan H, Rivkees SA. 2003. Oligodendrocytes express functional A1 adenosine receptors that stimulate cellular migration. Glia 44:166-172.
38. Panenka W, Jijon H, Herx LM, Armstrong JN, Feighan D, Wei T, Yong VW, Ransohoff RM, MacVicar BA. 2001. P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J Neurosci 21:7135-7142.
39. Ralevic V, Burntock G. 1998. Receptor for purines and pyrimidines. Pharmacol Rev 50:413-492.
40. Reynolds R, Hardy R. 1997. Oligodendroglial progenitors labeled with the 04 antibody persist in the adult rat cerebral cortex in vivo. J Neurosci Res 47:455-470.
41. Ryu JK, Choi HB, Hatori K, Heisel RL, Pelech SL, McLarnon JG, Kim SU. 2003. Adenosine triphosphate induces proliferation of human neural stem cells: role of calcium and p70 ribosomal protein S6 kinase. J Neurosci Res 72:352-362.
42. Scemes E, Duval N, Meda P. 2003. Reduced expression of P2Y1 receptors in connexin43-null mice alters calcium signaling and migration of neural progenitor cells. J Neurosci 23:11444-11452.
43. 2+ waves trigger responses in microglial cells in brain slices. FASEB J 16:255-257.
44. Soliven B. 2001. Calcium signalling in cell of oligodendroglial lineage. Microsc Res Tech 52:672-679.
45. Sommer I, Schachner M. 1981. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev Biol 83:311-327.
46. Stallcup WB. 1981. The NG2 antigen, a putative lineage marker: immunofluorescent localization in primary cultures of rat brain. Dev Biol 83:154-165.
47. Stallcup WB. 2002. The NG2 proteoglycan: past insights and future prospects. J Neurocytol 31:423-435.
48. Stevens B, Fields RD. 2000. Response of Schwann cells to action potentials in development. Science 24:2267-2271.
49. Stevens B, Porta S, Haak LL, Gallo V, Fields RD. 2002. Adenosine: a neuron-glial transmitter promoting myelination in the CNS in response to action potentials. Neuron 5:855-868.
50. Stevens B, Ishibashi T, Chen Jiang-Fan, Fields RD. 2004. Adenosine: an activity-dependent axonal signal regulating MAP kinase and proliferation in developing Schwann cells. Neuron Glia Biol 1:23-34.
51. Straub RH, Mayer M, Kreutz M, Leeb S, Scholmerich J, Falk W. 2000. Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. J Leukoc Biol 67:553-558.
52. Takeda M, Nelson DJ, Soliven B. 1995. Calcium signaling in cultured rat oligodendrocytes. Glia 14:225-236.
53. Tsai HH, Miller RH. 2002. Glial cell migration directed by axon guidance cues. Trends Neurosci 25:173-175.
54. Von Kügelgen I, Wetter A. 2000. Molecular pharmacology of P2Y-receptors. Naunyn-Schmiedebergs Arch Pharmacol 362:310-323.
55. Yoshioka K, Hosoda R, Kuroda Y, Nakata H. 2002. Hetero-oligomerization of adenosine A1 receptors with P2Y1 receptors in rat brains. FEBS Lett 531:299-303.
56. Yoshioka K, Saitoh O, Nakata H. 2001. Heteromeric association creates a P2Y-like adenosine receptor. Proc Natl Acad Sci USA 98:7617-7622.
57. Yuan X, Eisen AM, McBain CJ, Gallo V. 1998. A role for glutamate and its receptors in the regulation of oligodendrocyte development in cerebellar tissue slices. Development 125:2901-2914.
58. Zimmermann H, Braun N, Kegel B, Heine P. 1998. New insights into molecular structure and function of ectonucleotidases in the nervous system. Neurochem Int 32:421-425.